# BranchOut Food Inc.: financial statements, quarterly

BOF · Nasdaq · CIK 1962481 · [Consumer staples](/sectors/consumer-staples.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/bof.md) · [Financials](/companies/bof/financials.md) · [Filings](/companies/bof/filings.md) · [Insiders](/companies/bof/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/bof/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $k | [907](/filings/0001493152-24-045916.md) | [1,478 d](/filings/0001641172-25-004712.md) | [1,467](/filings/0001641172-25-010566.md) | [1,363](/filings/0001641172-25-023605.md) | [2,181](/filings/0001493152-25-021655.md) | [1,423 d](/filings/0001493152-26-014040.md) | [3,171](/filings/0001493152-26-023046.md) | [3,275](/filings/0001493152-26-037732.md) | [3,220](/filings/0001493152-25-021655.md) | [4,011 d](/filings/0001493152-26-014040.md) | [2,607](/filings/0001493152-26-023046.md) | [4,458](/filings/0001493152-26-037732.md) |
| Cost of revenue | $k | [935](/filings/0001493152-24-045916.md) | [1,499 d](/filings/0001641172-25-004712.md) | [1,183](/filings/0001641172-25-010566.md) | [1,214](/filings/0001641172-25-023605.md) | [1,845](/filings/0001493152-25-021655.md) | [1,410 d](/filings/0001493152-26-014040.md) | [2,641](/filings/0001493152-26-023046.md) | [2,693](/filings/0001493152-26-037732.md) | [2,650](/filings/0001493152-25-021655.md) | [3,705 d](/filings/0001493152-26-014040.md) | [2,206](/filings/0001493152-26-023046.md) | [4,361](/filings/0001493152-26-037732.md) |
| Gross profit | $k | [(27.6)](/filings/0001493152-24-045916.md) | [(20.6) d](/filings/0001641172-25-004712.md) | [284](/filings/0001641172-25-010566.md) | [149](/filings/0001641172-25-023605.md) | [336](/filings/0001493152-25-021655.md) | [13.1 d](/filings/0001493152-26-014040.md) | [530](/filings/0001493152-26-023046.md) | [582](/filings/0001493152-26-037732.md) | [570](/filings/0001493152-25-021655.md) | [306 d](/filings/0001493152-26-014040.md) | [401](/filings/0001493152-26-023046.md) | [96.8](/filings/0001493152-26-037732.md) |
| Research and development | $k | not reported | not reported | not reported | not reported | [(2.1) d](/filings/0001493152-25-021655.md) | [3.8 d](/filings/0001493152-26-014040.md) | not reported | not reported | [191 d](/filings/0001493152-25-021655.md) | [(201) d](/filings/0001493152-26-023046.md) | [16.6](/filings/0001493152-26-023046.md) | not reported |
| Operating income | $k | [(699)](/filings/0001493152-24-045916.md) | [(1,443) d](/filings/0001641172-25-004712.md) | [(1,025)](/filings/0001641172-25-010566.md) | [(826)](/filings/0001641172-25-023605.md) | [(903)](/filings/0001493152-25-021655.md) | [(1,148) d](/filings/0001493152-26-014040.md) | [(645)](/filings/0001493152-26-023046.md) | [(1,309)](/filings/0001493152-26-037732.md) | [(1,428)](/filings/0001493152-25-021655.md) | [(1,907) d](/filings/0001493152-26-014040.md) | [(1,619)](/filings/0001493152-26-023046.md) | [(2,565)](/filings/0001493152-26-037732.md) |
| Interest expense | $k | [10.0](/filings/0001493152-23-041182.md) | [29.3 d](/filings/0001641172-25-004712.md) | [28.7](/filings/0001641172-25-010566.md) | [119](/filings/0001641172-25-023605.md) | [371](/filings/0001493152-25-021655.md) | [345 d](/filings/0001493152-26-014040.md) | [278](/filings/0001493152-26-023046.md) | [301](/filings/0001493152-26-037732.md) | [149](/filings/0001493152-25-021655.md) | [127 d](/filings/0001493152-26-014040.md) | [175](/filings/0001493152-26-023046.md) | [185](/filings/0001493152-26-037732.md) |
| Net income | $k | [(706)](/filings/0001493152-24-045916.md) | [(1,469) d](/filings/0001641172-25-004712.md) | [(1,051)](/filings/0001641172-25-010566.md) | [(943)](/filings/0001641172-25-023605.md) | [(1,271)](/filings/0001493152-25-021655.md) | [(1,487) d](/filings/0001493152-26-014040.md) | [(918)](/filings/0001493152-26-023046.md) | [(1,603)](/filings/0001493152-26-037732.md) | [(1,573)](/filings/0001493152-25-021655.md) | [(2,031) d](/filings/0001493152-26-014040.md) | [(1,792)](/filings/0001493152-26-023046.md) | [(2,720)](/filings/0001493152-26-037732.md) |
| Diluted EPS | $ per share | [(0.18)](/filings/0001493152-24-045916.md) | not reported | [(0.26)](/filings/0001641172-25-010566.md) | [(0.22)](/filings/0001641172-25-023605.md) | [(0.19)](/filings/0001493152-25-021655.md) | not reported | [(0.11)](/filings/0001493152-26-023046.md) | [(0.17)](/filings/0001493152-26-037732.md) | [(0.14)](/filings/0001493152-25-021655.md) | not reported | [(0.12)](/filings/0001493152-26-023046.md) | [(0.18)](/filings/0001493152-26-037732.md) |
| Basic EPS | $ per share | [(0.18)](/filings/0001493152-24-045916.md) | not reported | [(0.26)](/filings/0001641172-25-010566.md) | [(0.22)](/filings/0001641172-25-023605.md) | [(0.19)](/filings/0001493152-25-021655.md) | not reported | [(0.11)](/filings/0001493152-26-023046.md) | [(0.17)](/filings/0001493152-26-037732.md) | [(0.14)](/filings/0001493152-25-021655.md) | not reported | [(0.12)](/filings/0001493152-26-023046.md) | [(0.18)](/filings/0001493152-26-037732.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [0.0](/filings/0001493152-23-041182.md) | [0.0](/filings/0001641172-25-004712.md) | [0.0](/filings/0001493152-24-019106.md) | [0.9](/filings/0001493152-24-032343.md) | [1.1](/filings/0001493152-24-045916.md) | [0.0](/filings/0001493152-26-014040.md) | [0.0](/filings/0001641172-25-010566.md) | [0.0](/filings/0001641172-25-023605.md) | [0.0](/filings/0001493152-25-021655.md) | [0.0](/filings/0001493152-26-037732.md) | [0.0](/filings/0001493152-26-023046.md) | [0.0](/filings/0001493152-26-037732.md) |
| Current assets | $m | [2.9](/filings/0001493152-23-041182.md) | [1.7](/filings/0001641172-25-004712.md) | [1.3](/filings/0001493152-24-019106.md) | [2.6](/filings/0001493152-24-032343.md) | [3.3](/filings/0001493152-24-045916.md) | [4.9](/filings/0001493152-26-014040.md) | [5.8](/filings/0001641172-25-010566.md) | [5.2](/filings/0001641172-25-023605.md) | [5.5](/filings/0001493152-25-021655.md) | [5.7](/filings/0001493152-26-037732.md) | [7.7](/filings/0001493152-26-023046.md) | [8.0](/filings/0001493152-26-037732.md) |
| Total assets | $m | [4.4](/filings/0001493152-23-041182.md) | [3.1](/filings/0001641172-25-004712.md) | [2.7](/filings/0001493152-24-019106.md) | [6.7](/filings/0001493152-24-032343.md) | [9.6](/filings/0001493152-24-045916.md) | [12.9](/filings/0001493152-26-014040.md) | [14.1](/filings/0001641172-25-010566.md) | [13.2](/filings/0001641172-25-023605.md) | [14.7](/filings/0001493152-25-021655.md) | [14.5](/filings/0001493152-26-037732.md) | [17.2](/filings/0001493152-26-023046.md) | [17.3](/filings/0001493152-26-037732.md) |
| Current liabilities | $m | [0.6](/filings/0001493152-23-041182.md) | [0.8](/filings/0001641172-25-004712.md) | [0.9](/filings/0001493152-24-019106.md) | [1.3](/filings/0001493152-24-032343.md) | [2.6](/filings/0001493152-24-045916.md) | [8.8](/filings/0001493152-26-014040.md) | [8.5](/filings/0001641172-25-010566.md) | [4.5](/filings/0001641172-25-023605.md) | [3.3](/filings/0001493152-25-021655.md) | [6.3](/filings/0001493152-26-037732.md) | [8.8](/filings/0001493152-26-023046.md) | [7.8](/filings/0001493152-26-037732.md) |
| Total liabilities | $m | [0.8](/filings/0001493152-23-041182.md) | [0.9](/filings/0001641172-25-004712.md) | [1.0](/filings/0001493152-24-019106.md) | [4.7](/filings/0001493152-24-032343.md) | [8.0](/filings/0001493152-24-045916.md) | [10.5](/filings/0001493152-26-014040.md) | [10.2](/filings/0001641172-25-010566.md) | [9.6](/filings/0001641172-25-023605.md) | [9.5](/filings/0001493152-25-021655.md) | [8.9](/filings/0001493152-26-037732.md) | [11.2](/filings/0001493152-26-023046.md) | [12.8](/filings/0001493152-26-037732.md) |
| Long-term debt | $m | [0.2](/filings/0001493152-23-041182.md) | [0.2](/filings/0001493152-24-012492.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | [1.0](/filings/0001493152-26-014040.md) | not reported | [3.5](/filings/0001493152-26-037732.md) |
| Current portion of debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | [3.9](/filings/0001493152-26-014040.md) | not reported | [3.7](/filings/0001493152-26-037732.md) |
| Shareholders' equity | $m | [3.6](/filings/0001493152-24-045916.md) | [2.2](/filings/0001493152-26-014040.md) | [1.7](/filings/0001641172-25-023605.md) | [2.0](/filings/0001493152-25-021655.md) | [1.5](/filings/0001493152-25-021655.md) | [2.3](/filings/0001493152-26-037732.md) | [3.9](/filings/0001493152-26-037732.md) | [3.5](/filings/0001493152-26-037732.md) | [5.1](/filings/0001493152-25-021655.md) | [5.6](/filings/0001493152-26-037732.md) | [5.9](/filings/0001493152-26-037732.md) | [4.5](/filings/0001493152-26-037732.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue, us-gaap:Cash
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt, us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $k | [(459) d](/filings/0001493152-24-045916.md) | [(271) d](/filings/0001641172-25-004712.md) | [(504)](/filings/0001641172-25-010566.md) | [(854) d](/filings/0001641172-25-023605.md) | [(1,902) d](/filings/0001493152-25-021655.md) | [(1,601) d](/filings/0001493152-26-014040.md) | [(1,937)](/filings/0001493152-26-023046.md) | [(2,026) d](/filings/0001493152-26-037732.md) | [(1,101) d](/filings/0001493152-25-021655.md) | [(1,936) d](/filings/0001493152-26-014040.md) | [(2,096)](/filings/0001493152-26-023046.md) | [(2,788) d](/filings/0001493152-26-037732.md) |
| Capital expenditure | $k | [56.5 d](/filings/0001493152-24-045916.md) | [50.0 d](/filings/0001641172-25-004712.md) | [50.0](/filings/0001641172-25-010566.md) | [526 d](/filings/0001641172-25-023605.md) | [1,544 d](/filings/0001493152-25-021655.md) | [727 d](/filings/0001493152-26-014040.md) | [378](/filings/0001493152-26-023046.md) | [113 d](/filings/0001493152-26-037732.md) | [82.7 d](/filings/0001493152-25-021655.md) | [173 d](/filings/0001493152-26-014040.md) | [515](/filings/0001493152-26-023046.md) | [205 d](/filings/0001493152-26-037732.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment

## Shares

| Line item | Unit | period not labelled (2022-09-30) | period not labelled (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [1.2](/filings/0001493152-23-041182.md) | [3.0](/filings/0001493152-24-019106.md) | [1.6](/filings/0001493152-24-032343.md) | [4.0](/filings/0001493152-24-045916.md) | [4.1](/filings/0001641172-25-010566.md) | [4.3](/filings/0001641172-25-023605.md) | [6.7](/filings/0001493152-25-021655.md) | [8.7](/filings/0001493152-26-023046.md) | [9.7](/filings/0001493152-26-037732.md) | [11.5](/filings/0001493152-25-021655.md) | [14.4](/filings/0001493152-26-023046.md) | [15.2](/filings/0001493152-26-037732.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 15,316,030 at 2026-08-13, from the cover of the [10-Q filed 2026-08-13](/filings/0001493152-26-037732.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:50 ET. No prices; not investment advice.